<DOC>
	<DOCNO>NCT02791750</DOCNO>
	<brief_summary>Non-persistence adjuvant hormonal therapy breast cancer 5 year decrease efficacy . The objective study know woman experience ( persistence , treatment change , quality life ) determinant , french population .</brief_summary>
	<brief_title>5 Years Follow-up With Adjuvant Therapy Women With Breast Invasive Carcinoma</brief_title>
	<detailed_description />
	<criteria>Patients followingup Lorraine Institute Oncology 5 year begin adjuvant hormonal therapy Women breast invasive carcinoma positiveRH indication adjuvant hormonal therapy Adult patient Being capable agree follow study procedure Patients inform nonopposed Covered social security History cancer except basal cell carcinoma Patients breast invasive carcinoma negativeRH Synchronous metastasis Relapsed Previous adjuvant hormonal therapy Men Patients guardianship</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hormone replacement therapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>follow</keyword>
</DOC>